Synta Provides Clinical Update and Reports Second Quarter 2012 Financial Results
07:15 EDT 2 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today reported financial
results for the quarter ended June 30, 2012 and provided clinical
program updates.
“We continue to make strong progress in advancing our ganetespib p...
Other Sources for this Article
Synta Pharmaceuticals Corp.
George Farmer, 781-541-7125
More From BioPortfolio on "Synta Provides Clinical Update and Reports Second Quarter 2012 Financial Results"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
